This patient group direction (PGD) is for the administration of live attenuated influenza vaccine (LAIV) nasal spray suspension as the first line vaccine and cell-cultured inactivated influenza vaccine (IIVc) to children aged 2 and 3 years old within a community pharmacy setting, in accordance with the childhood seasonal influenza vaccination advanced service specification and the national influenza immunisation programme. This PGD has been authorised by NHS England to facilitate delivery of the national immunisation programme in England.

A word version of this PGD is also available.

Published 3 September 2025.

Published 23 July 2025.

Published 21 July 2025.

Updated 26 August 2025.

This is a template only. The regional vaccination commissioning teams will provide a valid version with organisational authorisation.

This patient group direction is for the administration of inactivated influenza vaccine to individuals in accordance with the national influenza immunisation programme.

For community pharmacy providers, it is applicable for vaccination of individuals aged 18 years and over only.

This protocol is for the administration of inactivated influenza vaccine to individuals in accordance with the national influenza immunisation programme.

For community pharmacy providers, it is applicable for vaccination of individuals aged 18 years and over only.